Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings

Viral Infections, Non-HIV

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

N Engl J Med.

Bines JE, At Thobari J, Satria CD, Handley A, Watts E, Cowley D, Nirwati H, Ackland J, Standish J, Justice F, Byars G, Lee KJ, Barnes GL, Bachtiar NS, Viska Icanervilia A, Boniface K, Bogdanovic-Sakran N, Pavlic D, Bishop RF, Kirkwood CD, Buttery JP, Soenarto Y

doi: 10.1056/NEJMoa1706804.

Viral Infections, Non-HIV

Polio endgame: Lessons for the global rotavirus vaccination program

Vaccine.

Jiang B, Patel M, Glass RI

doi: 10.1016/j.vaccine.2019.04.023.

Viral Infections, Non-HIV

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Clin Infect Dis.

Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, Curns AT, Sulemana I, Esona MD, Bowen MD, Parashar UD, and the New Vaccine Surveillance Network (NVSN).

doi: 10.1093/cid/ciaa150.

Viral Infections, Non-HIV

Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

Pediatrics.

Hofstetter AM, Lacombe K, Klein EJ, Jones C, Strelitz B, Jacobson E, Ranade D, Ward ML, Mijatovic-Rustempasic S, Evans D, Wikswo M, Bowen MD, Parashar UD, Payne DC, Englund JA

doi: 10.1542/peds.2017-1110.

Bacterial Infections

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

Vaccine

Abu-Elyazeed R, Klein NP, Moerman L, Povey M, Pruitt A, Senders S, Silas P, Bi D, Rota-090 Study Group.

doi: 10.1016/j.vaccine.2020.08.070

Viral Infections, Non-HIV

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

Vaccine.

van de Witte S, Nauta J, Montomoli E, Weckx J

doi: 10.1016/

Further Publications Infectiology

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins

J Infect Dis

Karbiener M, Farcet MR, Schwaiger J, Powers N, Lenart J, Stewart JM, Tallman H, Kreil TR

doi: 10.1093/infdis/jiab482

Viral Infections, Non-HIV

Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019

Vaccine.

Mouratidou E, Lambrou A, Andreopoulou A, Gioula G, Exindari M, Kossyvakis A, Pogka V, Mentis A, Georgakopoulou T, Lytras T

doi: 10.1016/j.vaccine.2020.01.083.

Further Publications Infectiology

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials

Lancet Infect Dis

Mariz FC, Gray P, Bender N, Eriksson T, Kann H, Apter D, Paavonen J, Pajunen E, Prager KM, Sehr P, Surcel HM, Waterboer T, Müller M, Pawlita M, Lehtinen M

doi: 10.1016/S1473-3099(20)30873-2

Related content

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

Polio endgame: Lessons for the global rotavirus vaccination program

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins

Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials